Schneider and Osunkoya demonstrated that ERG immunoreactivity was comparable in ERG positive IDCP cases and adjacent invasive adjacent carcinoma, endorsing the assumption that intraductal carcinoma of the prostate probably represents colonization of benign glands by adjacent pre-existing conventional prostatic adenocarcinoma [27]. The gene discussed is ERG; the disease is prostate adenocarcinoma.